The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Vaccine Market Research Report 2025

Global Vaccine Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1735130

No of Pages : 103

Ask Your Query

Synopsis

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).

The global Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Vaccine in For Adult is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Vaccine include AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL, CureVac, Elanco, GSK and Hulan Bio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine.

Report Scope

The Vaccine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • AstraZeneca
  • BioNTech
  • Boehringer-Ingelheim
  • CCBIO
  • CSL
  • CureVac
  • Elanco
  • GSK
  • Hulan Bio
  • Indian Immunologicals
  • Merck
  • Minhai Biotechnology
  • Mitsubishi Tanabe Pharma
  • Moderna Therapeutics
  • Mylan
  • Plumbline Life Sciences
  • Sanofi
  • Translate Bio
  • Walvax Biotechnology
  • Wuhan Institute of Biological Products
  • Zoties

Segment by Type

  • Varicella Vaccine
  • Influenza Vaccine
  • Polio Vaccine
  • Hepatitis A Vaccine
  • Rabies Vaccine
  • BCG Vaccine
  • Hepatitis B
  • Pertussis, Diphtheria, Tetanus
  • Pneumococcal
  • Others

Segment by Application

  • For Adult
  • For Child

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Varicella Vaccine
1.2.3 Influenza Vaccine
1.2.4 Polio Vaccine
1.2.5 Hepatitis A Vaccine
1.2.6 Rabies Vaccine
1.2.7 BCG Vaccine
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Others
1.3 Market by Application
1.3.1 Global Vaccine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 For Adult
1.3.3 For Child
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vaccine Market Perspective (2019-2030)
2.2 Vaccine Growth Trends by Region
2.2.1 Global Vaccine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Vaccine Historic Market Size by Region (2019-2024)
2.2.3 Vaccine Forecasted Market Size by Region (2025-2030)
2.3 Vaccine Market Dynamics
2.3.1 Vaccine Industry Trends
2.3.2 Vaccine Market Drivers
2.3.3 Vaccine Market Challenges
2.3.4 Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaccine Players by Revenue
3.1.1 Global Top Vaccine Players by Revenue (2019-2024)
3.1.2 Global Vaccine Revenue Market Share by Players (2019-2024)
3.2 Global Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Vaccine Revenue
3.4 Global Vaccine Market Concentration Ratio
3.4.1 Global Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccine Revenue in 2023
3.5 Vaccine Key Players Head office and Area Served
3.6 Key Players Vaccine Product Solution and Service
3.7 Date of Enter into Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccine Breakdown Data by Type
4.1 Global Vaccine Historic Market Size by Type (2019-2024)
4.2 Global Vaccine Forecasted Market Size by Type (2025-2030)
5 Vaccine Breakdown Data by Application
5.1 Global Vaccine Historic Market Size by Application (2019-2024)
5.2 Global Vaccine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Vaccine Market Size (2019-2030)
6.2 North America Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Vaccine Market Size by Country (2019-2024)
6.4 North America Vaccine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Vaccine Market Size (2019-2030)
7.2 Europe Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Vaccine Market Size by Country (2019-2024)
7.4 Europe Vaccine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vaccine Market Size (2019-2030)
8.2 Asia-Pacific Vaccine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Vaccine Market Size by Region (2019-2024)
8.4 Asia-Pacific Vaccine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Vaccine Market Size (2019-2030)
9.2 Latin America Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Vaccine Market Size by Country (2019-2024)
9.4 Latin America Vaccine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaccine Market Size (2019-2030)
10.2 Middle East & Africa Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Vaccine Market Size by Country (2019-2024)
10.4 Middle East & Africa Vaccine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Vaccine Introduction
11.1.4 AstraZeneca Revenue in Vaccine Business (2019-2024)
11.1.5 AstraZeneca Recent Development
11.2 BioNTech
11.2.1 BioNTech Company Detail
11.2.2 BioNTech Business Overview
11.2.3 BioNTech Vaccine Introduction
11.2.4 BioNTech Revenue in Vaccine Business (2019-2024)
11.2.5 BioNTech Recent Development
11.3 Boehringer-Ingelheim
11.3.1 Boehringer-Ingelheim Company Detail
11.3.2 Boehringer-Ingelheim Business Overview
11.3.3 Boehringer-Ingelheim Vaccine Introduction
11.3.4 Boehringer-Ingelheim Revenue in Vaccine Business (2019-2024)
11.3.5 Boehringer-Ingelheim Recent Development
11.4 CCBIO
11.4.1 CCBIO Company Detail
11.4.2 CCBIO Business Overview
11.4.3 CCBIO Vaccine Introduction
11.4.4 CCBIO Revenue in Vaccine Business (2019-2024)
11.4.5 CCBIO Recent Development
11.5 CSL
11.5.1 CSL Company Detail
11.5.2 CSL Business Overview
11.5.3 CSL Vaccine Introduction
11.5.4 CSL Revenue in Vaccine Business (2019-2024)
11.5.5 CSL Recent Development
11.6 CureVac
11.6.1 CureVac Company Detail
11.6.2 CureVac Business Overview
11.6.3 CureVac Vaccine Introduction
11.6.4 CureVac Revenue in Vaccine Business (2019-2024)
11.6.5 CureVac Recent Development
11.7 Elanco
11.7.1 Elanco Company Detail
11.7.2 Elanco Business Overview
11.7.3 Elanco Vaccine Introduction
11.7.4 Elanco Revenue in Vaccine Business (2019-2024)
11.7.5 Elanco Recent Development
11.8 GSK
11.8.1 GSK Company Detail
11.8.2 GSK Business Overview
11.8.3 GSK Vaccine Introduction
11.8.4 GSK Revenue in Vaccine Business (2019-2024)
11.8.5 GSK Recent Development
11.9 Hulan Bio
11.9.1 Hulan Bio Company Detail
11.9.2 Hulan Bio Business Overview
11.9.3 Hulan Bio Vaccine Introduction
11.9.4 Hulan Bio Revenue in Vaccine Business (2019-2024)
11.9.5 Hulan Bio Recent Development
11.10 Indian Immunologicals
11.10.1 Indian Immunologicals Company Detail
11.10.2 Indian Immunologicals Business Overview
11.10.3 Indian Immunologicals Vaccine Introduction
11.10.4 Indian Immunologicals Revenue in Vaccine Business (2019-2024)
11.10.5 Indian Immunologicals Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Vaccine Introduction
11.11.4 Merck Revenue in Vaccine Business (2019-2024)
11.11.5 Merck Recent Development
11.12 Minhai Biotechnology
11.12.1 Minhai Biotechnology Company Detail
11.12.2 Minhai Biotechnology Business Overview
11.12.3 Minhai Biotechnology Vaccine Introduction
11.12.4 Minhai Biotechnology Revenue in Vaccine Business (2019-2024)
11.12.5 Minhai Biotechnology Recent Development
11.13 Mitsubishi Tanabe Pharma
11.13.1 Mitsubishi Tanabe Pharma Company Detail
11.13.2 Mitsubishi Tanabe Pharma Business Overview
11.13.3 Mitsubishi Tanabe Pharma Vaccine Introduction
11.13.4 Mitsubishi Tanabe Pharma Revenue in Vaccine Business (2019-2024)
11.13.5 Mitsubishi Tanabe Pharma Recent Development
11.14 Moderna Therapeutics
11.14.1 Moderna Therapeutics Company Detail
11.14.2 Moderna Therapeutics Business Overview
11.14.3 Moderna Therapeutics Vaccine Introduction
11.14.4 Moderna Therapeutics Revenue in Vaccine Business (2019-2024)
11.14.5 Moderna Therapeutics Recent Development
11.15 Mylan
11.15.1 Mylan Company Detail
11.15.2 Mylan Business Overview
11.15.3 Mylan Vaccine Introduction
11.15.4 Mylan Revenue in Vaccine Business (2019-2024)
11.15.5 Mylan Recent Development
11.16 Plumbline Life Sciences
11.16.1 Plumbline Life Sciences Company Detail
11.16.2 Plumbline Life Sciences Business Overview
11.16.3 Plumbline Life Sciences Vaccine Introduction
11.16.4 Plumbline Life Sciences Revenue in Vaccine Business (2019-2024)
11.16.5 Plumbline Life Sciences Recent Development
11.17 Sanofi
11.17.1 Sanofi Company Detail
11.17.2 Sanofi Business Overview
11.17.3 Sanofi Vaccine Introduction
11.17.4 Sanofi Revenue in Vaccine Business (2019-2024)
11.17.5 Sanofi Recent Development
11.18 Translate Bio
11.18.1 Translate Bio Company Detail
11.18.2 Translate Bio Business Overview
11.18.3 Translate Bio Vaccine Introduction
11.18.4 Translate Bio Revenue in Vaccine Business (2019-2024)
11.18.5 Translate Bio Recent Development
11.19 Walvax Biotechnology
11.19.1 Walvax Biotechnology Company Detail
11.19.2 Walvax Biotechnology Business Overview
11.19.3 Walvax Biotechnology Vaccine Introduction
11.19.4 Walvax Biotechnology Revenue in Vaccine Business (2019-2024)
11.19.5 Walvax Biotechnology Recent Development
11.20 Wuhan Institute of Biological Products
11.20.1 Wuhan Institute of Biological Products Company Detail
11.20.2 Wuhan Institute of Biological Products Business Overview
11.20.3 Wuhan Institute of Biological Products Vaccine Introduction
11.20.4 Wuhan Institute of Biological Products Revenue in Vaccine Business (2019-2024)
11.20.5 Wuhan Institute of Biological Products Recent Development
11.21 Zoties
11.21.1 Zoties Company Detail
11.21.2 Zoties Business Overview
11.21.3 Zoties Vaccine Introduction
11.21.4 Zoties Revenue in Vaccine Business (2019-2024)
11.21.5 Zoties Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock